Golden State Equity Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.22M | Buy |
3,018
+2,047
| +211% | +$830K | 0.23% | 103 |
|
2025
Q1 | $483K | Buy |
971
+22
| +2% | +$10.9K | 0.1% | 248 |
|
2024
Q4 | $494K | Buy |
949
+367
| +63% | +$191K | 0.09% | 238 |
|
2024
Q3 | $360K | Sell |
582
-37
| -6% | -$22.9K | 0.19% | 129 |
|
2024
Q2 | $342K | Buy |
+619
| New | +$342K | 0.07% | 297 |
|
2023
Q4 | $346K | Buy |
+651
| New | +$346K | 0.08% | 251 |
|
2023
Q3 | – | Sell |
-386
| Closed | -$201K | – | 354 |
|
2023
Q2 | $201K | Buy |
+386
| New | +$201K | 0.06% | 347 |
|
2022
Q1 | – | Sell |
-952
| Closed | -$635K | – | 221 |
|
2021
Q4 | $635K | Buy |
+952
| New | +$635K | 0.32% | 77 |
|